Efficacious, Orally Bioavailable Thrombin Inhibitors Based on 3-Aminopyridinone or 3-Aminopyrazinone Acetamide Peptidomimetic Templates
- 9 October 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (23) , 4466-4474
- https://doi.org/10.1021/jm980368v
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Discovery and Development of the Novel Potent Orally Active Thrombin Inhibitor N-(9-Hydroxy-9-fluorenecarboxy)prolyl trans-4-Aminocyclohexylmethyl Amide (L-372,460): Coapplication of Structure-Based Design and Rapid Multiple Analogue Synthesis on Solid SupportJournal of Medicinal Chemistry, 1998
- Antithrombotic Agents and Thromboembolic DiseaseNew England Journal of Medicine, 1997
- Small-molecule direct thrombin inhibitorsExpert Opinion on Therapeutic Patents, 1997
- CVS-1123, A Direct Thrombin Inhibitor, Prevents Occlusive Arterial and Venous Thrombosis in a Canine Model of Vascular InjuryJournal of Cardiovascular Pharmacology, 1997
- Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide AThrombosis Research, 1993
- A new synthesis of substituted 2(1H)‐pyrazinonesJournal of Heterocyclic Chemistry, 1983